Connect with Nurse Steven & The Medicare Nurses on all major Social Media Platforms
Connect with Nurse Steven & The Medicare Nurses on all major Social Media Platforms
Connect with Nurse Steven & The Medicare Nurses on all major Social Media Platforms
Connect with Nurse Steven & The Medicare Nurses on all major Social Media Platforms
GLP-1 Medication Guide

Ozempic vs Wegovy vs Mounjaro vs Zepbound

A side-by-side comparison for Medicare beneficiaries. Understand which medications are covered, what you may pay under the Bridge Program, and the qualifying conditions for each.

Feature
Ozempic
Semaglutide
Wegovy
Semaglutide
Mounjaro
Tirzepatide
Zepbound
Tirzepatide
ManufacturerNovo NordiskNovo NordiskEli LillyEli Lilly
How it worksGLP-1 receptor agonistGLP-1 receptor agonistDual GIP/GLP-1 receptor agonistDual GIP/GLP-1 receptor agonist
FDA-approved forType 2 diabetesChronic weight managementType 2 diabetesChronic weight management
Medicare coverageCovered under Medicare Part D when medically necessary for Type 2 diabetes.May be covered under Medicare Part D when prescribed for a qualifying condition under the Bridge Program.Covered under Medicare Part D when medically necessary for Type 2 diabetes.May be covered under Medicare Part D when prescribed for a qualifying condition under the Bridge Program.
Bridge Program priceAs low as $50/month for eligible beneficiaries through the Bridge Program.As low as $50/month for eligible beneficiaries through the Bridge Program.As low as $50/month for eligible beneficiaries through the Bridge Program.As low as $50/month for eligible beneficiaries through the Bridge Program.
DosingOnce-weekly injectionOnce-weekly injectionOnce-weekly injectionOnce-weekly injection
Important noteOften prescribed off-label for weight loss, but Medicare coverage requires a qualifying diagnosis.Same active ingredient as Ozempic, FDA-approved for weight loss.Also used off-label for weight loss; coverage depends on your plan and qualifying diagnosis.Same active ingredient as Mounjaro, FDA-approved for weight loss.

Medicare Bridge Program qualifying conditions

Medicare Part D may cover these GLP-1 medications only when prescribed for a qualifying medical condition. Eligibility varies by medication.

Type 2 Diabetes

You have been diagnosed with Type 2 diabetes and need medication to manage blood sugar.

Covered medications
OzempicWegovyMounjaroZepbound

Cardiovascular disease + obesity

You have established cardiovascular disease and a BMI of 27 or higher.

Covered medications
WegovyZepbound

Obstructive sleep apnea + obesity

You have diagnosed obstructive sleep apnea and a BMI of 30 or higher.

Covered medications
WegovyZepbound

Not sure which medication fits your situation?

Take the free 60-second quiz. A licensed Medicare agent will review your answers and help you understand your coverage and next steps.

Information is for educational purposes and does not guarantee coverage. Final eligibility and formulary decisions are made by your Medicare Part D plan and prescriber. For the latest official guidance, visit Medicare.gov — Weight Loss Drugs.